Translingual Neurostimulation: Evidence and VA Rehabilitation
Updated October 9, 2026. Translingual neurostimulation uses electrical stimulation delivered through a mouthpiece on the tongue. Its relevance to Veteran rehabilitation depends on the specific device, patient population, evidence, and supervised therapy program.
What Has FDA Authorized?
The Portable Neuromodulation Stimulator (PoNS) has a prescription indication for short-term treatment of gait deficits associated with mild to moderate multiple sclerosis in adults aged 22 and older, alongside supervised therapeutic exercise. See the FDA’s original authorization.
In May 2026, FDA also cleared PoNS for dynamic gait deficits associated with chronic stroke symptoms in adults aged 22 and older, again as an adjunct to supervised therapeutic exercise. See the FDA’s stroke clearance and indications.
Why This Matters for the VA
For companies seeking VA adoption, the opportunity starts with a defined rehabilitation use case. Identify the eligible patient group, the clinical team that would deliver treatment, the exercise protocol, and how progress will be measured.
Regulatory authorization establishes a permitted use. It does not establish VA purchasing, coverage, availability at every facility, or an outcome for an individual Veteran.
What the Evidence Must Answer
Evaluate evidence for the condition being treated and distinguish the effect of stimulation from the effect of the accompanying exercise program. Ask about the comparison group, size of the study, meaningful changes in walking, duration of follow-up, and adverse events.
Evidence for one condition should not be generalized to all neurological injuries or disorders. Claims about faster recovery, fewer falls, or lasting improvement need support from studies that actually measure those outcomes in the relevant population.
Turning a Device Into a Practical Program
VA readiness requires more than a portable device. Companies must address clinician training, patient selection, contraindications, scheduling, adherence, support, cost, and the acquisition path. These are the operational questions that determine whether a promising technology can fit a real rehabilitation service.
How JhetVet Helps
JhetVet helps medical device and health technology companies connect the evidence, clinical use case, operating requirements, and procurement strategy. Discuss your VA opportunity.
